Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuanhua Lu, Jie Ma, Jian Lin, Yafei Tian, Yongjun Ma, Wei Wang, Jialin Li, Hugang Zhang & Ping Jiao. (2021) Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy. Bioengineered 12:2, pages 12708-12721.
Read now
Read now
Bijay Dhungel, Aparna Jayachandran, Christopher J. Layton & Jason C. Steel. (2017) Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma. Drug Delivery 24:1, pages 289-299.
Read now
Read now
Articles from other publishers (19)
S. V. Kalinichenko, I. V. Korobko & M. V. Shepelev. (2021) Combination of ARE and HRE cis-Regulatory Elements Elevates the Activity of Tumor-Specific hTERT Promoter. Molecular Biology 55:4, pages 555-564.
Crossref
Crossref
Kirill N. Kashkin, Igor P. Chernov, Dmitry A. Didych & Eugene D. Sverdlov. (2017) Construction of a combinatorial library of chimeric tumor-specific promoters. BioTechniques 63:3, pages 107-116.
Crossref
Crossref
Kirill Kashkin, Igor Chernov, Elena Stukacheva, Galina Monastyrskaya, Natalya Uspenskaya, Eugene Kopantzev & Eugene Sverdlov. (2015) Cancer Specificity of Promoters of the Genes Controlling Cell Proliferation. Journal of Cellular Biochemistry 116:2, pages 299-309.
Crossref
Crossref
YUN HUA LI, LI FANG JIN, LIAN-FANG DU, QIU SHENG SHI, LONG LIU, XIAO JIA, YING WU, FAN LI & HANG HUI WANG. (2013) Enhancing HSP70-ShRNA transfection in 22RV1 prostate cancer cells by combination of sonoporation, liposomes and HTERT/CMV chimeric promoter. International Journal of Oncology 43:1, pages 151-158.
Crossref
Crossref
Leiying Miao, Kai Zhang, Chunyan Qiao, Xiangyu Jin, Changyu Zheng, Bai Yang & Hongchen Sun. (2013) Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle?mediated gene expression. Nanomedicine: Nanotechnology, Biology and Medicine 9:1, pages 141-150.
Crossref
Crossref
I. V. Alekseenko, M. V. Zinovyeva, V. V. Pleshkan & E. D. Sverdlov. (2012) Gene targeting in melanoma therapy: exploiting of surface markers and specific promoters. Biopolymers and Cell 28:1, pages 3-13.
Crossref
Crossref
M. L. Arendt, L. Nasir & I. M. Morgan. (2010) The human and canine TERT promoters function equivalently in human and canine cells. Veterinary and Comparative Oncology 8:4, pages 310-316.
Crossref
Crossref
Aya Mizrahi, Abraham Czerniak, Tally Levy, Smadar Amiur, Jennifer Gallula, Imad Matouk, Rasha Abu-lail, Vladimir Sorin, Tatiana Birman, Nathan de Groot, Abraham Hochberg & Patricia Ohana. (2009) Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. Journal of Translational Medicine 7:1.
Crossref
Crossref
X Yao, Y Yoshioka, T Morishige, Y Eto, H Watanabe, Y Okada, H Mizuguchi, Y Mukai, N Okada & S Nakagawa. (2009) Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis. Gene Therapy 16:12, pages 1395-1404.
Crossref
Crossref
Zhengkai Liao, Chenghu Huang, Fuxiang Zhou, Jie Xiong, Jie Bao, Hongyan Zhang, Wenjie Sun, Conghua Xie & Yunfeng Zhou. (2009) Radiation enhances suicide gene therapy in radioresistant laryngeal squamous cell carcinoma via activation of a tumor-specific promoter. Cancer Letters 283:1, pages 20-28.
Crossref
Crossref
Christopher M. Hine, Andrei Seluanov & Vera Gorbunova. (2008) Use of the Rad51 promoter for targeted anti-cancer therapy. Proceedings of the National Academy of Sciences 105:52, pages 20810-20815.
Crossref
Crossref
Hye Jin YunYoung-Hwa ChoYoungsun MoonYoung Woo ParkHye-Kyoung YoonYeun-Ju KimSung-Ha ChoYoung-Ill LeeBong-Su KangWun-Jae KimKeerang ParkWongi Seol. (2008) Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2. Experimental and Molecular Medicine 40:3, pages 345.
Crossref
Crossref
Xinglei Yao, Yasuo Yoshioka, Yusuke Eto, Tomohiro Morishige, Yuka Okada, Hiroyuki Mizuguchi, Yohei Mukai, Naoki Okada & Shinsaku Nakagawa. (2007) TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection. Biochemical and Biophysical Research Communications 362:2, pages 419-424.
Crossref
Crossref
Helen B. Fleisig & Judy M.Y. Wong. (2007) Telomerase as a clinical target: Current strategies and potential applications. Experimental Gerontology 42:1-2, pages 102-112.
Crossref
Crossref
Binghua Li, Xinran Liu, Junkai Fan, Rong Qi, Linan Bo, Jinfa Gu, Qijun Qian, Cheng Qian & Xinyuan Liu. (2006) A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potentialin vivo. The Journal of Gene Medicine 8:10, pages 1232-1242.
Crossref
Crossref
D Sarkar, E S Park & P B Fisher. (2006) Defining the mechanism by which IFN-β dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35). Cell Death & Differentiation 13:9, pages 1541-1553.
Crossref
Crossref
Chang-Qing Su. (2006) Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma. World Journal of Gastroenterology 12:47, pages 7613.
Crossref
Crossref
Devanand Sarkar, Zao-zhong Su, Nicolaq Vozhilla, Eun Sook Park, Aaron Randolph, Kristoffer Valerie & Paul B. Fisher. (2005) Targeted Virus Replication Plus Immunotherapy Eradicates Primary and Distant Pancreatic Tumors in Nude Mice. Cancer Research 65:19, pages 9056-9063.
Crossref
Crossref
Ralf Janknecht. (2004) On the road to immortality: hTERT upregulation in cancer cells. FEBS Letters 564:1-2, pages 9-13.
Crossref
Crossref